Rapid-acting insulin analogues;Kortwerkende insulineanaloga

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 8, 1998, Pages 397-400

  Wolffenbuttel, B H R ^a,b   Heine, R J ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN DERIVATIVE;

CLINICAL FEATURE; DOSE RESPONSE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; POSTPRANDIAL STATE; REVIEW;

DIABETES MELLITUS, TYPE 1; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE;

EID: 0032554292     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Ballegooie E van, Heine RJ. Behandeling diabetes mellitus type I. In: Ballegooie E van, Heine RJ, redacteuren. Diabetes mellitus, 2e dr. Utrecht: Bunge, 1995.
2. Zimmerman BR. Glycaemia control in diabetes mellitus. Towards the normal profile? Drugs 1994;47:611-21.
3. Zinman B. The physiologic replacement of insulin. An elusive goal. N Engl J Med 1989;321:363-70.
4. Holleman F, Hoekstra JBL. Insulin lispro. N Engl J Med 1997; 337:176-83.
5. Jorgensen LN, Dideriksen LH, Dreier K, Carcinogenic effect of the human insulin analogue Bio Asp in female rats. Diabetologia 1992;35(Suppl 1):A3.
6. DiMarchi RD, Chance RE, Long HB, Shields JE, Slieker LJ. Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I. Horm Res 1994;41 Suppl 2:93-6.
7. Garg SK, Carmain JA, Braddy KC, Anderson JH, Vignati L, Jennings MK, et al. Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type I diabetes. Diabet Med 1996;13 47-52.
8. Heinemann L, Heise T, Wahl LC, Trautmann ME, Ampudia J, Starke AA, et al. Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue (Lys(B28), Pro(B29)) human insulin, Diabet Med 1996;13:625-9.
9. Hanaire H, Bringer J, Lassmann-Vague V, Jeandidier N, Meyer L, Blin P, et al. Improvement of HbA1c without increasing hypoglycemia risk in diabetic patients treated with insulin lispro in external pumps. Diabetologia 1997;40(Suppl 1):A10.
10. Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T. Insulin lispro in CSII; results of a double-blind crossover study. Diabetes 1997; 46:440-3.
11. Anderson jr JH, Brunelle RL, Koivisto VA, Pfutzner A, Trautmann ME, Vignati L, et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes 1997;46:265-70.
12. Ahmed AME, Home PD. Reduced nocturnal hypoglycaemia with insulin analogue lispro in type I diabetic patients. Diabetologia 1997;40(Suppl 1):A10.
13. Rowe R, Anderson JH, Gale E. A double-blind comparison of insulin LisPro and regular insulin in patients on a multiple injection regimen. Diabetes 1997;45(Suppl 2):71A.
14. Fineberg NS, Fineberg SE, Anderson JH, Birkett MA, Gibson RG, Hufferd S. Immunologic effects of insulin lispro (Lys (B28), Pro (B29) human insulin) in IDDM and NIDDM patients previously treated with insulin. Diabetes 1996;45:1750-4.
15. Holleman F, Brand JJG van den, Hoven RA, Linden JM van der, Tweel I van der, Hoekstra JB, et al. Comparison of LysB28, ProB29-human insulin analog and regular human insulin in the correction of incidental hyperglycemia. Diabetes Care 1996;19:1426-9.
16. Jacobs MAJM, Keulen ETP, Kanc K, Casteleijn S, Scheffer P, Deville W, et al. Metabolic efficacy of preprandial administration of Lys(B28), Pro(B29) human insulin analog in IDDM patients. A comparison with human regular insulin during a three-meal test period. Diabetes Care 1997;20:1279-86.
17. Ebeling P, Jansson PA, Smith U, Lalli C, Bolli GB, Koivisto VA. Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin. Diabetes Care 1997;20:1287-9.
18. Burge MR, Castillo KR, Schade DS, Meal composition is a determinant of lispro-induced hypoglycemia in IDDM. Diabetes Care 1997;20:152-5.
19. Torlone E, Pampanelli S, Lalli C, Del Sindaco P, Di Vincenzo A, Rambotti AM, et al. Effects of the short-acting insulin analog (Lys(B28), Pro(B29)) on postprandial blood glucose control in IDDM. Diabetes Care 1996;19:945-52.